WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'0701 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 4'1941 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 7'936  7'777  7'621  7'470  7'322  6'236  4'904  3'636 
Births 208  206  205  203  202  197  189  158 
Surviving infants 203  201  200  198  197  191  180  147 
Pop. less than 5 years 989  980  970  962  956  943  845  672 
Pop. less than 15 years 2'836  2'820  2'804  2'792  2'781  2'643  2'229  1'707 
Female 15-49 years 2'074  2'021  1'969  1'917  1'866  1'495  1'105  785 

Number of reported case

(Click for retrospective incidence data for Honduras)
Diphtheria
Japanese encephalitis
Measles 8'360  4'188 
Mumps 138  143  172  187  219  853 
Pertussis 48  113  135  127  224  169  65  2'503 
Polio*
Rubella 201 
Rubella (CRS)
Tetanus (neonatal) 39 
Tetanus (total) 17  14  16  21  12  62  31 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Honduras)
Vaccine year result method % card seen                                                
BCG 2011  99  DHS   89.7  90  99*  99*  100  99*  99  70  25 
DTP1 2011  99  DHS   89.7  88  99*  99*  100  96  98 
DTP3 2011  95  DHS   89.7  88  99*  99*  98  93  94  84  28 
HepB_BD          98  98  99  98  95 
HepB3 2011  95  DHS   89.7  88  99*  99*  98  93  94 
Hib3 2011  95  DHS   89.7  88  99*  99*  98  93  94 
JapEnc         
MCV 2011  88  DHS   89.7  93  99*  99*  100  95  98  90  31 
MCV2         
PCV1          88  99* 
PCV3          88  78 
Pol3 2011  96  DHS   89.7  88  99*  99*  98  93  88  87  31 
Rota1          87  99*  99*  98 
Rota_last          87  99*  98  82 
Rubella1          93  99*  99*  100  95 
TT2plus 2000  16  FHS   87.2  99*  99*  99*  80  100  49 
PAB         
VAD1          94  81  78  84  87  84 
YFV          100  100  100  100  88 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Honduras)
BCG 90  93  97  99  99  99  70  25 
DTP1 88  92  96  99  96  98  94  53 
DTP3 88  91  95  98  93  94  84  28 
HepB3 88  91  95  98  93  94 
Hib3 88  91  95  98  93  94 
MCV 93  95  98  99  95  98  90  31 
PAB 94  94  94  94  94  93  60 
PCV3 88  78 
Pol3 88  91  95  98  93  88  87  31 
Rota_last 87  93  98  82 

Number of districts in the country 298  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 44
From 80 to 89% 34
From 50 to 79% 23
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 4 years; Yes risk groups
DTwP 18 months; 4 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB birth; 1st contact, +1, +6 months for risk groups
IPV 2, 4, 6 months; Yes risk groups
Influenza 6-35 months (x2); 3-9 years; > 60 years; Yes and risk groups
MMR 12 months; Yes
MR 13 years; Yes risk groups
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; Yes
Td 11, 21 years; Yes and 3 doses for pregnant women not yet vaccinated
VitaminA 6 months to 4 years (x2); Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2010-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 112  110  110  104  110  141  141 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 298  298  298  298  298  298  298 
Nº districts with DTP3 coverage >=80% number 230  289  281  285  266  213  233 
% of districts with DTP3 coverage >=80% From 0 to 100% 77  97  94  96  89  71  78 
Nº districts with measles (MCV1) coverage >=95% number 165  250  212  199  161     
% of districts with MCV1 coverage >=95% From 0 to 100% 55  84  71  67  54     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 45  NA  63  71  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.